NP / PA
Blair, Melissa
Blair, Melissa was paid $125K by Medicaid between Jan 2018 and Apr 2019, across 7 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 57% of everything it billed.
33Billing provider infoBLAIR, MELISSA
SEVIERVILLE, TN 37862
SEVIERVILLE, TN 37862
33aNPI1821248717assigned 09/26/2008
33bProvider typeFamily Nurse Practitioner
28Total paid$125K
24GClaims2,920
24DCodes billed7
24AFirst – last monthJan 2018 – Apr 2019
Compared with peers
Next to other Family Nurse Practitioner providers in Tennessee
Rank by total paid#129 of 687
Median peer was paid$15K
This provider vs. median8.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,998 | $99K | |
| 2019 | 922 | $26K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 57% | 1,185 | 881 | $71K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 35% | 485 | 379 | $44K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4.5% | 756 | 268 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.2% | 393 | 273 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 33 | 25 | $1K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 20 | 12 | $4.52 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 48 | 42 | $1.48 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.